glyburide and rosiglitazone

glyburide has been researched along with rosiglitazone in 80 studies

Research

Studies (80)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (1.25)	18.2507
2000's	45 (56.25)	29.6817
2010's	31 (38.75)	24.3611
2020's	3 (3.75)	2.80

Authors

Authors	Studies
Chander, R; Chaturvedi, D; Ray, S; Srivastava, AK	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Bhatia, G; Kumar, A; Maurya, RA; Sharma, S; Srivastava, AK; Srivastava, SP; Tamrakar, AK; Tripathi, VD	1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ	1
Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S	1
Ahmad, P; Gupta, LP; Kumar, A; Rahuja, N; Sharma, S; Srivastava, AK; Srivastava, SP; Tamrakar, AK	1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR	1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Aleo, MD; Bonin, PD; Luo, Y; Potter, DM; Swiss, R; Will, Y	1
Alam, MS; Alam, P; Ali, Y; Bano, S; Dhulap, A; Haider, S; Hamid, H; Javed, K; Kharbanda, C; Nazreen, S; Pasha, MA; Shafi, S	1
Alam, MS; Ali, Y; Bano, S; Dhulap, A; Hamid, H; Javed, K; Kharbanda, C	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Darvesh, AS; Geldenhuys, WJ; Leeper, TC; Morris, DL; Sullivan, PG; Yonutas, HM	1
Norman, BH	1
Aaronson, PI; Mishra, SK	1
Gomis, R; Jones, NP; Patwardhan, RN; Squatrito, S; Wolffenbuttel, BH	1
Meneilly, GS; Tessier, D	1
Braddon, J; Phillips, P	1
Berry, RA; Freed, MI; Greene, DA; Haffner, SM; Heise, MA; Herman, WH; Holman, RR; Jones, NP; Kahn, SE; Lachin, JM; Levy, D; Viberti, G; Zinman, B	1
Dandona, P; Dole, JF; Freed, M; Murphy, K; Patel, J; Patwardhan, R; Rendell, M; St John Sutton, M	1
Chow, WH; Davies, C; Jiang, J; Li, GW; Pan, CY; Shi, HL; Sun, XC; Tian, H; Yang, WY; Zhu, XX	1
Rochester, CD; Samuel, J	1
Bell, CF; Botteman, MF; Braunstein, SN; Devine, ST; Ramsdell, JW; Stephens, JM	1
Campbell, RK; Iltz, JL; Setter, SM; Thams, J	1
Harman-Boehm, I; Hershkovitz, T; Mouritzen, U; Raz, I; Vaz, J; Wainstein, J	1
James, R; Kerenyi, Z; Samer, H; Stewart, M; Yan, Y	1
Bruce, S; Dailey, GE; Fiedorek, FT; Noor, MA; Park, JS	1
Haslbeck, M; Jakob, S; Kellerer, M; Linn, T	1
Kiselevich, A; London, D; Magen, E; Priluk, R; Viskoper, RJ; Volchek, L; Yosefy, C	1
Biswas, N; Freed, MI; Porter, LE; Smith, SA	1
Hunt, MJ; Morton, AJ	1
Cobitz, AR; Freed, MI; Rood, JA; Ryan, CM; Strachan, MW; Waterhouse, BR	1
Bruce, S; Garber, A; Klein, E; Mohideen, P; Sankoh, S	1
Choudhury, H; Harisudhan, T; Mullangi, R; Srinivas, NR; Venkatesh, P	1
Kulenović, I	1
Chen, JW; Jen, HL; Lin, SJ; Yin, WH; Young, MS	1
Almoznino-Sarafian, D; Alon, I; Berman, S; Cohen, N; Efrati, S; Gorelik, O; Shteinshnaider, M; Weissgarten, J	1
Bakris, GL; Freed, MI; Heise, MA; McMorn, SO; Porter, LE; Ruilope, LM; Weston, WM	1
Freed, MI; Haffner, S; Heise, MA; Herman, WH; Holman, R; Jones, NP; Kahn, SE; Kravitz, B; Lachin, J; O'Neill, MC; Viberti, G; Zinman, B	1
Haffner, SM; Heise, MA; Herman, WH; Holman, RR; Jones, NP; Kahn, SE; Kravitz, BG; Lachin, JM; O'Neill, MC; Viberti, G; Zinman, B	1
Nathan, DM	1
Hanefeld, M; Jones, NP; Patwardhan, R	1
Ari, N; Aslamaci, S; Irat, AM; Karasu, C	1
Scheen, AJ	1
Garg, R	1
Einecke, D	1
Betteridge, DJ; Chow, WS; Hoo, RLC; Lam, KSL; Tan, KCB; Tse, HF; Tso, AWK; Xu, A	1
Matthaei, S	1
Atkinson, LL; Benkoczi, C; Finegood, DT; McDonald-Dyck, C	1
Cobitz, AR; Davidson, JA; McMorn, SO; Waterhouse, BR	1
Bank, AJ; Gonzalez-Campoy, JM; Kaiser, DR; Kelly, AS; Thelen, AM	1
Aftring, RP; Haffner, SM; Heise, MA; Herman, WH; Holman, RR; Kahn, SE; Kravitz, BG; Lachin, JM; Viberti, G; Yu, D; Zinman, B	1
Dachs, R; Darby-Stewart, A; Graber, MA	1
Ahmed, MS; Fokina, V; Hankins, GD; Hemauer, S; Mattison, D; Nanovskaya, TN; Patrikeeva, S	1
Bajirovic, V; Byun, J; Kellogg, A; Oral, E; Pennathur, S; Pop-Busui, R; Raffel, D; Stevens, MJ; Vivekanandan-Giri, A	1
McGill, JB	1
Haffner, SM; Herman, WH; Holman, RR; Kahn, SE; Kravitz, BG; Lachin, JM; Paul, G; Viberti, G; Yu, D; Zinman, B	1
Aftring, RP; Haffner, SM; Herman, WH; Holman, RR; Jones, NP; Kahn, SE; Kravitz, BG; Lachin, JM; Paul, G; Viberti, G; Zinman, B	1
Ahmed, MS; Hankins, GD; Hemauer, SJ; Nanovskaya, TN; Patrikeeva, SL	1
Cross, JT; Gardner, JS; Garrison, LP; Veenstra, DL	1
Aftring, RP; Haffner, SM; Herman, WH; Holman, RR; Kahn, SE; Kravitz, BG; Lachin, JM; Paul, G; Viberti, G; Zinman, B	2
Gadzhanova, S; Gillies, M; Roughead, E; Zuo, Y	1
Doubova, SV; Flores-Hernández, S; Mino-León, D; Reyes-Morales, H	1
Greyson, CR; Lu, L; Reiter, MJ; Sarraf, M; Schwartz, GG; Ye, S	1
Barr, AM; Boyda, HN; Hawkes, E; Honer, WG; Jin, CH; Pang, CC; Procyshyn, RM; Tse, L	1
Brooks-Worrell, BM; Palmer, JP	1
Boyko, EJ; Floyd, JS; Forsberg, CW; Moore, K; Riley, K; Smith, NL; Wheeler, S	1
Chow, WS; Lam, KS; Shiu, SW; Tan, KC; Wong, Y; Xiao, SM	1
Asiri, Y; Barr, AM; Boyda, HN; Honer, WG; Lo, R; Pang, CC; Procyshyn, RM; Wang, CK; Wu, C	1
Adams, LA; Bedwell, DW; Calvert, NA; Cassidy, KC; Cramer, JW; Mohutsky, MA; Moulton, RD; Rougée, LR; Ruterbories, KJ; Yumibe, NP; Zhou, X	1
Areosa Sastre, A; González-Colaço Harmand, M; Martínez, G; Vernooij, RW	1
Chen, SH; Liu, XN; Peng, Y; Sun, QY	1
Abbulu, K; Bhende, SD; Varanasi, MB	1
Jannetto, PJ; Langman, LJ	1

Reviews

10 review(s) available for glyburide and rosiglitazone

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Drug Induced Liver Injury (DILI). Mechanisms and Medicinal Chemistry Avoidance/Mitigation Strategies. Journal of medicinal chemistry, 2020, 10-22, Volume: 63, Issue:20 Topics: Animals; Cell Line; Cell Survival; Chemical and Drug Induced Liver Injury; Drug Discovery; Drug Evaluation, Preclinical; Hepatocytes; Humans; Liver; Mitochondria, Liver; Pharmaceutical Preparations; Risk Assessment; Tissue Distribution	2020
Diabetes in elderly adults. The journals of gerontology. Series A, Biological sciences and medical sciences, 2001, Volume: 56, Issue:1 Topics: Adult; Aged; Diabetes Mellitus, Type 2; Diet Therapy; Exercise; Female; Glyburide; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Risk Factors; Rosiglitazone; Thiazoles; Thiazolidinediones; United States	2001
Oral hypoglycaemics. When not to use what. Australian family physician, 2002, Volume: 31, Issue:7 Topics: Acarbose; Acidosis, Lactic; Aged; Contraindications; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Hypoglycemic Agents; Male; Metformin; Pioglitazone; Renal Insufficiency; Rosiglitazone; Thiazoles; Thiazolidinediones	2002
Combination agents for diabetes. Advance for nurse practitioners, 2003, Volume: 11, Issue:6 Topics: Adult; Diabetes Mellitus, Type 2; Drug Combinations; Female; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Metformin; Rosiglitazone; Thiazoles; Thiazolidinediones	2003
Metformin hydrochloride in the treatment of type 2 diabetes mellitus: a clinical review with a focus on dual therapy. Clinical therapeutics, 2003, Volume: 25, Issue:12 Topics: Clinical Trials as Topic; Contraindications; Diabetes Mellitus, Type 2; Drug Interactions; Drug Therapy, Combination; Glyburide; Humans; Hypoglycemic Agents; Metformin; Rosiglitazone; Sulfonylurea Compounds; Thiazolidinediones	2003
[Continuation 50. Type 2 diabetes: possibilities and limitations of pharmacological therapy]. MMW Fortschritte der Medizin, 2003, Dec-18, Volume: 145, Issue:51-52 Topics: 1-Deoxynojirimycin; Acarbose; Aged; Blood Glucose; Carbamates; Contraindications; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Enzyme Inhibitors; Fasting; Follow-Up Studies; Germany; Glucosamine; Glyburide; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemia; Hypoglycemic Agents; Imino Pyranoses; Insulin; Metformin; Middle Aged; Nateglinide; Obesity; Patient Compliance; Phenylalanine; Pioglitazone; Piperidines; Practice Guidelines as Topic; Risk Factors; Rosiglitazone; Sulfonylurea Compounds; Thiazolidinediones; Time Factors	2003
Selecting among ADA/EASD tier 1 and tier 2 treatment options. The Journal of family practice, 2009, Volume: 58, Issue:9 Suppl Tr Topics: Administration, Oral; Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Glyburide; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Male; Metformin; Practice Guidelines as Topic; Prognosis; Risk Assessment; Rosiglitazone; Severity of Illness Index; Thiazolidinediones; Treatment Outcome	2009
Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia. The Cochrane database of systematic reviews, 2017, 06-15, Volume: 6 Topics: Carbamates; Cause of Death; Cognition Disorders; Diabetes Mellitus, Type 2; Glyburide; Humans; Hypoglycemic Agents; Memory Disorders; Metformin; Piperidines; Randomized Controlled Trials as Topic; Rosiglitazone; Thiazolidinediones	2017
Efficacy of different antidiabetic drugs based on metformin in the treatment of type 2 diabetes mellitus: A network meta-analysis involving eight eligible randomized-controlled trials. Journal of cellular physiology, 2019, Volume: 234, Issue:3 Topics: Blood Glucose; Diabetes Mellitus, Type 2; Drug Combinations; Exenatide; Female; Glyburide; Humans; Male; Metformin; Network Meta-Analysis; Pioglitazone; Randomized Controlled Trials as Topic; Rosiglitazone; Sulfonylurea Compounds; Vildagliptin	2019

Trials

29 trial(s) available for glyburide and rosiglitazone

Article	Year
Addition of low-dose rosiglitazone to sulphonylurea therapy improves glycaemic control in Type 2 diabetic patients. Diabetic medicine : a journal of the British Diabetic Association, 2000, Volume: 17, Issue:1 Topics: Adult; Aged; Blood Glucose; C-Peptide; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Europe; Female; Fructosamine; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Rosiglitazone; Safety; Thiazoles; Thiazolidinediones; Triglycerides	2000
A diabetes outcome progression trial (ADOPT): an international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes. Diabetes care, 2002, Volume: 25, Issue:10 Topics: Albuminuria; Blood Glucose; Diabetes Mellitus, Type 2; Disease Progression; Double-Blind Method; Glyburide; Humans; Hypoglycemic Agents; Metformin; Research Design; Rosiglitazone; Safety; Thiazoles; Thiazolidinediones; Time Factors; Treatment Failure; Treatment Outcome	2002
A comparison of the effects of rosiglitazone and glyburide on cardiovascular function and glycemic control in patients with type 2 diabetes. Diabetes care, 2002, Volume: 25, Issue:11 Topics: Adult; Aged; Blood Glucose; Blood Pressure; Body Mass Index; Cardiovascular Physiological Phenomena; Cardiovascular System; Diabetes Mellitus, Type 2; Female; Glyburide; Glycated Hemoglobin; Hemodynamics; Humans; Hypoglycemic Agents; Male; Middle Aged; Placebos; Racial Groups; Rosiglitazone; Safety; Thiazoles; Thiazolidinediones; Time Factors; Ventricular Function, Left	2002
Addition of rosiglitazone to existing sulfonylurea treatment in chinese patients with type 2 diabetes and exposure to hepatitis B or C. Diabetes technology & therapeutics, 2003, Volume: 5, Issue:1 Topics: Adult; Asian People; Blood Glucose; China; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Environmental Exposure; Female; Gliclazide; Glyburide; Glycated Hemoglobin; Hepatitis B; Hepatitis C; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Rosiglitazone; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones	2003
Addition of biphasic insulin aspart 30 to rosiglitazone in type 2 diabetes mellitus that is poorly controlled with glibenclamide monotherapy. Clinical therapeutics, 2003, Volume: 25, Issue:12 Topics: Adult; Aged; Biphasic Insulins; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Fructosamine; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Aspart; Insulin, Isophane; Male; Middle Aged; Rosiglitazone; Thiazolidinediones; Treatment Outcome	2003
Combination therapy with rosiglitazone and glibenclamide compared with upward titration of glibenclamide alone in patients with type 2 diabetes mellitus. Diabetes research and clinical practice, 2004, Volume: 63, Issue:3 Topics: Adult; Aged; Aged, 80 and over; C-Peptide; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Fasting; Fatty Acids, Nonesterified; Female; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Placebos; Rosiglitazone; Thiazolidinediones; Triglycerides	2004
Glycemic control with glyburide/metformin tablets in combination with rosiglitazone in patients with type 2 diabetes: a randomized, double-blind trial. The American journal of medicine, 2004, Feb-15, Volume: 116, Issue:4 Topics: Adult; Aged; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Rosiglitazone; Thiazolidinediones	2004
Rosiglitazone improves, while Glibenclamide worsens blood pressure control in treated hypertensive diabetic and dyslipidemic subjects via modulation of insulin resistance and sympathetic activity. Journal of cardiovascular pharmacology, 2004, Volume: 44, Issue:2 Topics: Administration, Oral; Albuminuria; Blood Glucose; Blood Pressure; Body Mass Index; Brachial Artery; Cholesterol, LDL; Cilazapril; Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug Therapy, Combination; Endothelial Cells; Endothelium, Vascular; Evoked Potentials; Female; Glyburide; Glycated Hemoglobin; Heart Rate; Humans; Hyperlipidemias; Hypertension; Insulin; Insulin Resistance; Kidney; Male; Rosiglitazone; Simvastatin; Skin Physiological Phenomena; Sympathetic Nervous System; Thiazolidinediones; Time Factors; Ultrasonography; Vasodilation	2004
Rosiglitazone, but not glyburide, reduces circulating proinsulin and the proinsulin:insulin ratio in type 2 diabetes. The Journal of clinical endocrinology and metabolism, 2004, Volume: 89, Issue:12 Topics: Aged; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Female; Glyburide; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Proinsulin; Rosiglitazone; Thiazolidinediones	2004
Improving metabolic control leads to better working memory in adults with type 2 diabetes. Diabetes care, 2006, Volume: 29, Issue:2 Topics: Adult; Aged; Blood Glucose; Cognition; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Glyburide; Humans; Hypoglycemic Agents; Male; Memory; Metformin; Middle Aged; Psychological Tests; Rosiglitazone; Stress, Psychological; Thiazolidinediones	2006
Metformin-glibenclamide versus metformin plus rosiglitazone in patients with type 2 diabetes inadequately controlled on metformin monotherapy. Diabetes, obesity & metabolism, 2006, Volume: 8, Issue:2 Topics: Adult; Aged; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Fasting; Female; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Lipid Metabolism; Male; Metformin; Middle Aged; Rosiglitazone; Tablets; Thiazolidinediones; Treatment Outcome	2006
Impact of rosiglitazone on glycaemic control, insulin levels and blood pressure values in patients with type 2 diabetes. Medicinski arhiv, 2006, Volume: 60, Issue:3 Topics: Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Glyburide; Humans; Hypoglycemic Agents; Insulin; Middle Aged; Rosiglitazone; Thiazolidinediones	2006
Differential effects of peroxisome proliferator-activated receptor ligands and sulfonylurea plus statin treatment on plasma concentrations of adipokines in type 2 diabetes with dyslipidemia. Diabetes & metabolism, 2006, Volume: 32, Issue:3 Topics: Adiponectin; Aged; Blood Glucose; Body Mass Index; Cohort Studies; Cytokines; Diabetes Mellitus, Type 2; Dyslipidemias; Female; Glyburide; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Inflammation; Ligands; Lipids; Male; Middle Aged; Peroxisome Proliferator-Activated Receptors; Rosiglitazone; Sulfonylurea Compounds; Thiazolidinediones	2006
Rosiglitazone reduces microalbuminuria and blood pressure independently of glycemia in type 2 diabetes patients with microalbuminuria. Journal of hypertension, 2006, Volume: 24, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Blood Pressure; Cohort Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Glyburide; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Rosiglitazone; Thiazolidinediones	2006
A Diabetes Outcome Progression Trial (ADOPT): baseline characteristics of Type 2 diabetic patients in North America and Europe. Diabetic medicine : a journal of the British Diabetic Association, 2006, Volume: 23, Issue:12 Topics: Adult; Age Distribution; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Europe; Female; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin Resistance; Male; Metabolic Syndrome; Metformin; Middle Aged; North America; Racial Groups; Rosiglitazone; Sex Distribution; Thiazolidinediones	2006
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. The New England journal of medicine, 2006, Dec-07, Volume: 355, Issue:23 Topics: Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Kaplan-Meier Estimate; Male; Metformin; Middle Aged; Proportional Hazards Models; Rosiglitazone; Thiazolidinediones; Treatment Outcome; Waist-Hip Ratio; Weight Gain	2006
A one-year study comparing the efficacy and safety of rosiglitazone and glibenclamide in the treatment of type 2 diabetes. Nutrition, metabolism, and cardiovascular diseases : NMCD, 2007, Volume: 17, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Fatty Acids, Nonesterified; Female; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; Rosiglitazone; Thiazolidinediones	2007
[ADOPT study: which first-line glucose-lowering oral medication in type 2 diabetes?]. Revue medicale de Liege, 2007, Volume: 62, Issue:1 Topics: Administration, Oral; Belgium; Canada; Cost-Benefit Analysis; Diabetes Mellitus, Type 2; Double-Blind Method; European Union; Glyburide; Humans; Hypoglycemic Agents; Metformin; Middle Aged; Quality of Life; Rosiglitazone; Thiazolidinediones; Treatment Outcome; United States	2007
Thiazolidinedione increases serum soluble receptor for advanced glycation end-products in type 2 diabetes. Diabetologia, 2007, Volume: 50, Issue:9 Topics: Adult; Aged; Blood Glucose; Blood Pressure; Body Mass Index; Diabetes Mellitus, Type 2; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Female; Glyburide; Humans; Hypoglycemic Agents; Male; Middle Aged; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Rosiglitazone; Thiazolidinediones	2007
A 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study of the efficacy and tolerability of combination therapy with rosiglitazone and sulfonylurea in African American and Hispanic American patients with type 2 diabetes Clinical therapeutics, 2007, Volume: 29, Issue:9 Topics: Black or African American; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Glyburide; Hispanic or Latino; Humans; Hypoglycemic Agents; Male; Middle Aged; Rosiglitazone; Thiazolidinediones	2007
Rosiglitazone improves endothelial function and inflammation but not asymmetric dimethylarginine or oxidative stress in patients with type 2 diabetes mellitus. Vascular medicine (London, England), 2007, Volume: 12, Issue:4 Topics: Adult; Aged; Arginine; Biomarkers; Blood Glucose; Blood Pressure; Brachial Artery; C-Reactive Protein; Carotid Arteries; Diabetes Mellitus; Double-Blind Method; Drug Therapy, Combination; Elasticity; Endothelium, Vascular; Female; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Inflammation; Insulin; Male; Metformin; Middle Aged; Oxidative Stress; Rosiglitazone; Thiazolidinediones; Treatment Outcome; Vasodilation	2007
Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT). Diabetes care, 2008, Volume: 31, Issue:5 Topics: Age of Onset; Aged; Diabetes Mellitus, Type 2; Disease Progression; Female; Fractures, Bone; Glyburide; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Rosiglitazone; Thiazolidinediones; Treatment Outcome	2008
Impact of rosiglitazone and glyburide on nitrosative stress and myocardial blood flow regulation in type 2 diabetes mellitus. Metabolism: clinical and experimental, 2009, Volume: 58, Issue:7 Topics: Adiponectin; Adult; Blood Glucose; C-Reactive Protein; Cohort Studies; Coronary Vessels; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Lipid Metabolism; Male; Middle Aged; Myocardium; Positron-Emission Tomography; Reactive Nitrogen Species; Rosiglitazone; Thiazolidinediones; Tyrosine; von Willebrand Factor	2009
Rosiglitazone decreases C-reactive protein to a greater extent relative to glyburide and metformin over 4 years despite greater weight gain: observations from a Diabetes Outcome Progression Trial (ADOPT). Diabetes care, 2010, Volume: 33, Issue:1 Topics: Adult; Aged; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Rosiglitazone; Thiazolidinediones; Time; Treatment Outcome; Weight Gain	2010
Effect of rosiglitazone, metformin, and glyburide on bone biomarkers in patients with type 2 diabetes. The Journal of clinical endocrinology and metabolism, 2010, Volume: 95, Issue:1 Topics: Adult; Aged; Biomarkers; Bone and Bones; Bone Resorption; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glyburide; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Osteogenesis; Rosiglitazone; Thiazolidinediones	2010
Effects of rosiglitazone, glyburide, and metformin on β-cell function and insulin sensitivity in ADOPT. Diabetes, 2011, Volume: 60, Issue:5 Topics: Aged; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Hypoglycemic Agents; Insulin Resistance; Insulin-Secreting Cells; Male; Metformin; Middle Aged; Rosiglitazone; Thiazolidinediones	2011
Renal function in type 2 diabetes with rosiglitazone, metformin, and glyburide monotherapy. Clinical journal of the American Society of Nephrology : CJASN, 2011, Volume: 6, Issue:5 Topics: Adult; Aged; Albuminuria; Blood Glucose; Blood Pressure; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Follow-Up Studies; Glomerular Filtration Rate; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Kidney; Male; Metformin; Middle Aged; Rosiglitazone; Thiazolidinediones; Treatment Outcome	2011
Attenuation of islet-specific T cell responses is associated with C-peptide improvement in autoimmune type 2 diabetes patients. Clinical and experimental immunology, 2013, Volume: 171, Issue:2 Topics: Adult; Aged; Autoantibodies; Autoimmunity; C-Peptide; Cells, Cultured; Diabetes Mellitus, Type 2; Disease Progression; Female; Follow-Up Studies; Glyburide; Humans; Hypoglycemic Agents; Immunosuppression Therapy; Interferon-gamma; Interleukin-12; Islets of Langerhans; Male; Middle Aged; PPAR gamma; Rosiglitazone; T-Cell Antigen Receptor Specificity; T-Lymphocytes; Thiazolidinediones	2013
Carbamylation of LDL and its relationship with myeloperoxidase in type 2 diabetes mellitus. Clinical science (London, England : 1979), 2014, Volume: 126, Issue:2 Topics: Adult; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Glyburide; Glycated Hemoglobin; Humans; Lipoproteins, LDL; Male; Middle Aged; Peroxidase; Rosiglitazone; Thiazolidinediones	2014

Other Studies

41 other study(ies) available for glyburide and rosiglitazone

Article	Year
Omega-(2-Naphthyloxy) amino alkanes as a novel class of anti-hyperglycemic and lipid lowering agents. Bioorganic & medicinal chemistry, 2008, Mar-01, Volume: 16, Issue:5 Topics: Alkanes; Alkylation; Amination; Animals; Hypoglycemic Agents; Hypolipidemic Agents; Lipid Metabolism; Male; Molecular Structure; Naphthalenes; PPAR gamma; Rats; Structure-Activity Relationship	2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Design and synthesis of 2,4-disubstituted polyhydroquinolines as prospective antihyperglycemic and lipid modulating agents. Bioorganic & medicinal chemistry, 2010, Jun-01, Volume: 18, Issue:11 Topics: Animals; Diabetes Mellitus, Experimental; Drug Design; Dyslipidemias; Glycogen Phosphorylase; Hypoglycemic Agents; Mice; Mice, Inbred Strains; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Quinolines	2010
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics	2010
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors	2012
Synthesis of propiophenone derivatives as new class of antidiabetic agents reducing body weight in db/db mice. Bioorganic & medicinal chemistry, 2012, Mar-15, Volume: 20, Issue:6 Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Eating; Hypoglycemic Agents; Hypolipidemic Agents; Lipids; Male; Mice; Mice, Inbred C57BL; Propiophenones; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Rats; Rats, Sprague-Dawley; Rats, Wistar; Streptozocin; Weight Loss	2012
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions. Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10 Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection	2012
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship	2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump. Hepatology (Baltimore, Md.), 2014, Volume: 60, Issue:3 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Chemical and Drug Induced Liver Injury; Humans; Male; Mitochondria, Liver; Rats; Rats, Sprague-Dawley; Severity of Illness Index	2014
Novel benzenesulfonylureas containing thiophenylpyrazoline moiety as potential antidiabetic and anticancer agents. Bioorganic & medicinal chemistry letters, 2014, Nov-15, Volume: 24, Issue:22 Topics: 3T3-L1 Cells; Animals; Antineoplastic Agents; Binding Sites; Catalytic Domain; Cell Line; Cell Proliferation; Diabetes Mellitus, Experimental; Drug Screening Assays, Antitumor; Glucose Tolerance Test; Hypoglycemic Agents; Mice; Molecular Docking Simulation; PPAR gamma; Pyrazoles; Rats; Rats, Wistar; Structure-Activity Relationship; Sulfonylurea Compounds	2014
Antidiabetic effect of novel benzenesulfonylureas as PPAR-γ agonists and their anticancer effect. Bioorganic & medicinal chemistry letters, 2015, Oct-15, Volume: 25, Issue:20 Topics: Animals; Antineoplastic Agents; Cell Proliferation; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Hypoglycemic Agents; Models, Molecular; Molecular Structure; PPAR gamma; Pyrazoles; Rats; Rats, Wistar; Streptozocin; Structure-Activity Relationship; Sulfonylurea Compounds	2015
Identification of small molecules that bind to the mitochondrial protein mitoNEET. Bioorganic & medicinal chemistry letters, 2016, 11-01, Volume: 26, Issue:21 Topics: Hypoglycemic Agents; Ligands; Mitochondrial Proteins; Protein Binding; Small Molecule Libraries; Thiazolidinediones	2016
Differential block by troglitazone and rosiglitazone of glibenclamide-sensitive K(+) current in rat aorta myocytes. European journal of pharmacology, 1999, Dec-10, Volume: 386, Issue:1 Topics: Animals; Aorta, Thoracic; Chromans; Glyburide; Hypoglycemic Agents; In Vitro Techniques; Male; Membrane Potentials; Muscle, Smooth, Vascular; Potassium Channel Blockers; Rats; Rats, Wistar; Rosiglitazone; Thiazoles; Thiazolidinediones; Troglitazone	1999
Economic model of first-line drug strategies to achieve recommended glycaemic control in newly diagnosed type 2 diabetes mellitus. PharmacoEconomics, 2003, Volume: 21, Issue:11 Topics: Carbamates; Cohort Studies; Decision Trees; Diabetes Mellitus, Type 2; Direct Service Costs; Drug Costs; Drug Therapy, Combination; Glipizide; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Managed Care Programs; Markov Chains; Metformin; Models, Economic; Piperidines; Rosiglitazone; Thiazoles; Thiazolidinediones; United States	2003
Atypical diabetes associated with inclusion formation in the R6/2 mouse model of Huntington's disease is not improved by treatment with hypoglycaemic agents. Experimental brain research, 2005, Volume: 166, Issue:2 Topics: Administration, Oral; Animals; Behavior, Animal; Diabetes Mellitus; Disease Models, Animal; Exocytosis; Glucose Intolerance; Glyburide; Glycosuria; Huntington Disease; Hypoglycemic Agents; Insulin; Insulin-Secreting Cells; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Neurologic Mutants; Mice, Transgenic; Rosiglitazone; Thiazolidinediones	2005
Simultaneous estimation of six anti-diabetic drugs--glibenclamide, gliclazide, glipizide, pioglitazone, repaglinide and rosiglitazone: development of a novel HPLC method for use in the analysis of pharmaceutical formulations and its application to human p Biomedical chromatography : BMC, 2006, Volume: 20, Issue:10 Topics: Carbamates; Chromatography, High Pressure Liquid; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Molecular Structure; Pioglitazone; Piperidines; Reproducibility of Results; Rosiglitazone; Thiazolidinediones	2006
Total cellular calcium and magnesium content of cultured human peripheral blood mononuclear cells following exposure to antidiabetic drugs. Acta diabetologica, 2006, Volume: 43, Issue:2 Topics: Adult; Calcium; Cells, Cultured; Diazoxide; Glyburide; Humans; Hypoglycemic Agents; Leukocytes; Magnesium; Metformin; Middle Aged; Potassium Channels; Rosiglitazone; Thiazolidinediones	2006
Thiazolidinediones for initial treatment of type 2 diabetes? The New England journal of medicine, 2006, Dec-07, Volume: 355, Issue:23 Topics: Algorithms; Diabetes Mellitus, Type 2; Glyburide; Humans; Hypoglycemic Agents; Metformin; Rosiglitazone; Thiazolidinediones; Weight Gain	2006
Alteration of vascular reactivity in diabetic human mammary artery and the effects of thiazolidinediones. The Journal of pharmacy and pharmacology, 2006, Volume: 58, Issue:12 Topics: Aged; Cromakalim; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endothelium, Vascular; Female; Glyburide; Humans; Hypoglycemic Agents; Male; Mammary Arteries; Middle Aged; Nitroprusside; Phenylephrine; Pioglitazone; Potassium Channel Blockers; Potassium Chloride; Rosiglitazone; Thiazolidinediones; Vasoconstriction	2006
Glycemic durability of monotherapy for diabetes. The New England journal of medicine, 2007, Mar-29, Volume: 356, Issue:13 Topics: Diabetes Mellitus, Type 2; Glyburide; Humans; Hypoglycemic Agents; Insulin-Secreting Cells; Metformin; Rosiglitazone; Thiazolidinediones	2007
[ADOPT study. Glitazone controls diabetes progression]. MMW Fortschritte der Medizin, 2007, Volume: 149, Issue:1-2 Topics: Blood Glucose; Diabetes Mellitus, Type 2; Disease Progression; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Long-Term Care; Metformin; Middle Aged; Randomized Controlled Trials as Topic; Rosiglitazone; Thiazolidinediones	2007
[ADOPT study: Reevaluation of antidiabetic drugs. Control of diabetes]. MMW Fortschritte der Medizin, 2007, Apr-12, Volume: 149, Issue:15 Topics: Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Disease Progression; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Metformin; Rosiglitazone; Thiazolidinediones; Treatment Outcome	2007
[Consulting Prof. Dr. Stephan Matthaei. Quakenbrück diabetes center. Prescription relevant conclusions]. MMW Fortschritte der Medizin, 2007, Apr-12, Volume: 149, Issue:15 Topics: Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glyburide; Humans; Hypoglycemic Agents; Long-Term Care; Metformin; Rosiglitazone; Thiazolidinediones; Treatment Outcome	2007
Effect of chronic rosiglitazone, metformin and glyburide treatment on beta-cell mass, function and insulin sensitivity in mZDF rats. Diabetes, obesity & metabolism, 2008, Volume: 10, Issue:9 Topics: Animals; Apoptosis; Blood Glucose; Glyburide; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin-Secreting Cells; Male; Metformin; Models, Biological; Random Allocation; Rats; Rats, Zucker; Rosiglitazone; Thiazolidinediones	2008
Choosing first-line therapy for management of type 2 diabetes. American family physician, 2008, Jan-01, Volume: 77, Issue:1 Topics: Diabetes Mellitus, Type 2; Glyburide; Humans; Hypoglycemic Agents; Metformin; Rosiglitazone; Thiazolidinediones	2008
Effect of albumin on transplacental transfer and distribution of rosiglitazone and glyburide. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2008, Volume: 21, Issue:3 Topics: Female; Fetal Blood; Glyburide; Humans; Hypoglycemic Agents; In Vitro Techniques; Maternal-Fetal Exchange; Placental Circulation; Pregnancy; Rosiglitazone; Serum Albumin; Thiazolidinediones	2008
Role of human placental apical membrane transporters in the efflux of glyburide, rosiglitazone, and metformin. American journal of obstetrics and gynecology, 2010, Volume: 202, Issue:4 Topics: Adenosine Triphosphate; Biological Transport; Carbon Radioisotopes; Carrier Proteins; Cell Polarity; Diabetes, Gestational; Drug Interactions; Female; Glyburide; Humans; Hypoglycemic Agents; Maternal-Fetal Exchange; Metformin; Microvilli; Placenta; Pregnancy; Rosiglitazone; Thiazolidinediones; Tritium	2010
Can modeling of health outcomes facilitate regulatory decision making? The benefit-risk tradeoff for rosiglitazone in 1999 vs. 2007. Clinical pharmacology and therapeutics, 2011, Volume: 89, Issue:3 Topics: Decision Making, Organizational; Diabetes Mellitus, Type 2; Drug Approval; Female; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Models, Theoretical; Outcome Assessment, Health Care; Quality-Adjusted Life Years; Rosiglitazone; Thiazolidinediones; United States; United States Food and Drug Administration	2011
Fixed dose combination diabetes medicines - usage in the Australian veteran population. Australian family physician, 2011, Volume: 40, Issue:10 Topics: Aged; Aged, 80 and over; Australia; Diabetes Mellitus, Type 2; Drug Combinations; Drug Prescriptions; Female; Glyburide; Humans; Hypoglycemic Agents; Male; Metformin; Practice Patterns, Physicians'; Rosiglitazone; Thiazolidinediones; Veterans	2011
Postmarketing pharmacovigilance of adverse drug reactions: the case of rosiglitazone in Mexico. International journal of clinical pharmacology and therapeutics, 2012, Volume: 50, Issue:1 Topics: Administration, Oral; Adult; Aged; Diabetes Mellitus, Type 2; Drug Combinations; Edema; Female; Follow-Up Studies; Glyburide; Humans; Hypoglycemic Agents; Male; Medication Adherence; Metformin; Mexico; Middle Aged; Pharmacovigilance; Prospective Studies; Rosiglitazone; Thiazoles; Thiazolidinediones; Weight Gain	2012
Thiazolidinedione drugs promote onset, alter characteristics, and increase mortality of ischemic ventricular fibrillation in pigs. Cardiovascular drugs and therapy, 2012, Volume: 26, Issue:3 Topics: Animals; Anti-Arrhythmia Agents; Coronary Vessels; Death, Sudden, Cardiac; Decanoic Acids; Female; Glyburide; Hydroxy Acids; Hypoglycemic Agents; Ischemia; Ischemic Preconditioning, Myocardial; Male; Pioglitazone; Potassium Channel Blockers; Rosiglitazone; Swine; Thiazolidinediones; Ventricular Fibrillation	2012
Differential effects of 3 classes of antidiabetic drugs on olanzapine-induced glucose dysregulation and insulin resistance in female rats. Journal of psychiatry & neuroscience : JPN, 2012, Volume: 37, Issue:6 Topics: Animals; Antipsychotic Agents; Benzodiazepines; Female; Glucose Intolerance; Glyburide; Hypoglycemic Agents; Insulin Resistance; Metformin; Olanzapine; Rats; Rosiglitazone; Thiazolidinediones	2012
Mortality among veterans with type 2 diabetes initiating metformin, sulfonylurea or rosiglitazone monotherapy. Diabetologia, 2013, Volume: 56, Issue:9 Topics: Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Proportional Hazards Models; Retrospective Studies; Risk Factors; Rosiglitazone; Sulfonylurea Compounds; Thiazolidinediones; Time Factors; United States; Veterans	2013
Antidiabetic-drug combination treatment for glucose intolerance in adult female rats treated acutely with olanzapine. Progress in neuro-psychopharmacology & biological psychiatry, 2014, Jan-03, Volume: 48 Topics: Animals; Benzodiazepines; Disease Models, Animal; Drug Therapy, Combination; Fasting; Female; Glucose Intolerance; Glucose Tolerance Test; Glyburide; Hypoglycemic Agents; Insulin; Metformin; Olanzapine; Rats; Rats, Sprague-Dawley; Rosiglitazone; Selective Serotonin Reuptake Inhibitors; Thiazolidinediones; Time Factors	2014
Difference in the Pharmacokinetics and Hepatic Metabolism of Antidiabetic Drugs in Zucker Diabetic Fatty and Sprague-Dawley Rats. Drug metabolism and disposition: the biological fate of chemicals, 2016, Volume: 44, Issue:8 Topics: Administration, Intravenous; Animals; Biotransformation; Canagliflozin; Chromans; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Glucuronosyltransferase; Glyburide; Hepatocytes; Humans; Hypoglycemic Agents; Liver; Male; Metformin; Rats, Sprague-Dawley; Rats, Zucker; Rosiglitazone; Species Specificity; Substrate Specificity; Sulfotransferases; Thiazolidinediones; Troglitazone	2016
A Sensitive HPTLC Method for the Estimation of Glibenclamide, Rosiglitazone Maleate and Metformin Hydrochloride from a Multicomponent Dosage Form. Journal of chromatographic science, 2020, Apr-25, Volume: 58, Issue:5 Topics: Calibration; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Glyburide; Limit of Detection; Metformin; Reproducibility of Results; Rosiglitazone; Tablets	2020
Analysis of Hypoglycemic Drugs by Liquid Chromatography-Tandem Mass Spectrometry. Methods in molecular biology (Clifton, N.J.), 2024, Volume: 2737 Topics: Chlorpropamide; Chromatography, High Pressure Liquid; Chromatography, Liquid; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Nateglinide; Pioglitazone; Rosiglitazone; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Tolazamide; Tolbutamide	2024